According to the updated trade data from the General Administration of Customs of the People's Republic of China, 2FIRSTS has analyzed the e-cigarette exports to Russia in September 2023. The details are as follows:
The export volume reached approximately 33.3 million dollars, recording a month-on-month increase of 5.56% but a year-on-year decline of 24.05%.
The export volume was approximately 709 tons, marking a sequential growth of 3.34% but a year-on-year decline of 1.99%.
The export unit price increased by 2.14% to $46.96 per kilogram, but decreased by 22.51% compared to the same period last year. The average price for "e-cigarettes and similar personal electronic vaporizers" was $8.16 per unit.
Among them, "e-cigarettes and similar personal electronic vaporizers" accounted for 21.37% of the export category, while "non-combustible products containing nicotine, without tobacco or reconstituted tobacco" accounted for 78.63%.
According to data from Statista, it is predicted that the revenue of the e-cigarette market in Russia will reach $1.1 billion by 2023. The market is expected to have an annual growth rate of 2.80% from 2023 to 2028. Taking into account the total population figures, it is estimated that the per capita consumption in Russia will be approximately $8.93 in 2023. With increasing consumer demand and tightening regulations, the e-cigarette market in Russia is beginning to transition from rapid growth.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
